Leptin and resistin levels in serum of patients with hematologic malignancies: Correlation with clinical characteristics

Experimental Oncology

Volumn 28, Issue 3, 2006, Pages 241-244

  Pamuk, G E ^a   Demir, M ^a   Harmandar, F ^a   Yesil Y ^a   Turgut, B ^a   Vural, O ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Chronic lymphocytic leukemia; Leptin; Lymphoma; Multiple myeloma; Resistin

Indexed keywords

CD38 ANTIGEN; HEMOGLOBIN; LEPTIN; RESISTIN;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BODY MASS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THROMBOCYTE COUNT;

ADIPOSE TISSUE; ADULT; AGED; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LEPTIN; LIPID METABOLISM; MALE; MIDDLE AGED; RESISTIN;

EID: 33750964853     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet Med 2004; 21: 497-501.
2. Hino M, Nakao T, Yamane T, Ohta K, Takubo T, Tatsumi N. Leptin receptor and leukemia. Leuk Lymphoma 2000; 36: 457-61.
3. Wilson CA, Bekele G, Nicolson M, Ravussin E, Pratley RE. Relationship of the white blood cell count to body fat: role of leptin. Br J Haematol 1997; 99: 447-51.
4. Nakao T, Hino M, Yamane T, Hishizawa Y, Morii H, Tatsumi N. Expression of the leptin receptor in human leukemic blast cells. Br J Haematol 1998; 102: 740-5.
5. Gainsford T, Willson TA, Metcalf D, Handman E, Mc Farlane C, Nq A, Nicola NA, Alexander WS, Hilton DJ. Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells. Proc Nat Acad Sci USA 1996; 93: 14564-8.
6. Laharrague P, Corberand J, Penicaud L, Casteilla L. Relationship of human plasma leptin concentration with blood cell parameters. Haematologica 2000; 85: 993-4.
7. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932-9.
8. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Bichem Biophys Res Commun 2003; 309: 286-90.
9. Banerjee RR, Lazar MA. Resistin: molecular history and prognosis. J Mol Med 2003; 81: 218-26.
10. International Workshop on CLL. Chronic lymphocytic leukemia: recommedations for diagnosis, staging and response criteria. Ann Intern Med 1989; 110: 236-8.
11. Rai K, Sawitsky A, Cronkite E, Chanana AB, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-34.
12. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1.
13. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842-54.
14. Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, Kornblau SM, Dong J, Kliche KO, Jiang S, Snodgrass HR, Estey EH, Andreeff M. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 1999; 93: 1668-76.
15. Bruserud O, Huang TS, Glenjen N, Gjertsen BT, Foss B. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts. Haematologica 2002; 87: 584-95.
16. Togo M, Tsukamoto K, Satoh H, Hara M, Futamura A, Nakarai H, Nakahara K, Hashimoto Y. Relationship between levels of leptin and hemoglobin in Japanese men. Blood 1999; 93: 4444-5.
17. Hirose H, Saito I, Kawai T, Nakamura K, Maruyama H, Saruta T. Serum leptin level: possible association with haematopoiesis in adolescents, independent of body mass index and serum insulin. Clin Sci 1998; 94: 633-6.
18. Mikhail AA, Beck EX, Shafer A, Barut B, Gbur JS, Zupancic TJ, Schweitzer AC, Cioffi JA, Lacaud G, Ouyang B, Keller G, Snodgrass HR. Leptin stimulates fetal and adult erythroid and myeloid development. Blood 1997; 89: 1507-12.
19. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverse starvation-induced immunosuppression. Nature 1998; 394: 897-901.
20. Harle P, Pongratz G, Weidler C, Buttner R, Scholmerich J, Straub RH. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2004; 63: 809-16.
21. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pmeumonia. J Immunol 2002; 168: 4018-24.
22. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 15: 2565-71.
23. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.